Oct 1 (Reuters) – JCR Pharmaceuticals Co Ltd: * JCR PHARMACEUTICALS ANNOUNCES LICENSING AGREEMENT WITH MENAGEN TO COMMERCIALIZE AGALSIDASE BETA BS I.V. INFUSION ACROSS NINE MENAT MARKETS * JCR PHARMACEUTICALS CO LTD: DOES NOT EXPECT A MATERIAL IMPACT ON FY2025 CONSOLIDATED RESULTS FROM MENAGEN DEAL Source text: Further company coverage: ;))
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Parents can help youngsters regain their motivation by creating successes. Making their progress visible will…
Berlin (dpa) – Bread and baked goods top the list of food items we wind…
Check out these tips to get the best out of your air fryer, from how…
A gene-edited pig kidney kept a man off dialysis for nine months in a world…
Rome (PA Media/dpa) - Cases of diabetes develop earlier and are more severe in women who…
Berlin (dpa) - Municipalities in many places around the globe have at least one dedicated…